HOME >> BIOLOGY >> NEWS
Taxanes may enhance immunity in breast cancer patients

COLUMBUS, Ohio Breast cancer patients treated with taxanes as part of their chemotherapy regimen have stronger immune systems one year after completing therapy than do women undergoing similar treatments without taxanes a finding that turns conventional medical wisdom on its head.

Researchers in the Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute studied 227 women enrolled in a multi-year study examining the relationship between stress and immunity in women with breast cancer. They divided the group into women who received taxanes as part of their treatment (55) and those who did not (172).

Researchers took blood from the patients and measured levels of key markers of the patients' immune status at two points in time, immediately after the women joined the study and one year following completion of treatment. Their analysis of the blood looked at the activity of the patient's T cells (white blood cells that can fight infections and cancer cells) and natural killer (NK) cells (another type of white blood cell that can kill cancer cells and cells infected with viruses).

They found that T cell growth was 37 percent higher and that the cancer killing activity of the NK cells was 39 percent higher in women receiving taxanes versus those who did not.

Scientists controlled for multiple variables that might contribute to the strength of the patients' immune function, including age, menopausal status, hormone receptor status, treatment, hormonal therapy at 12 months and cell counts, among others.

"This was totally unexpected," says Dr. William Carson, a surgeon and associate director of clinical research for the OSUCCC-James. "Most oncologists believe taxanes just like the rest of the chemotherapeutic agents we use suppress the immune system, not enhance it."

The study is published in the May 15 issue of Clinical Cancer Research.

Carson sa
'"/>

Contact: Michelle Gailiun
gailiun.1@osu.edu
614-293-3737
Ohio State University
6-May-2004


Page: 1 2

Related biology news :

1. Potential for enhanced sequestration of carbon in soils supports evaluations
2. Probing the surface of white blood cells to enhance immune system medicine
3. Protective gene may enhance vaccine responses
4. Plant gene discovery could enhance plant growth, reduce fertilizer needs and phosphate pollution
5. Technology could enhance accuracy of breast biopsy
6. Manipulating biotope space can enhance beneficial biodiversity effects
7. UC Riverside researchers develop low-carb corn with enhanced protein and oil
8. Athletics, genetic enhancement and ethics
9. Carnegie Mellon enhances Quantum Dot Corp. technology for long-term, live-animal imaging
10. Practice-based interventions enhance quality of care
11. Scientists discover potential approaches to enhance existing cancer therapies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
Breaking Biology News(10 mins):
(Date:5/22/2016)... ... 2016 , ... Doctors in Rome say micronutrients found in certain foods have ... Mesothelioma has just posted an article on the new research. Click here to ... Sciences and Translational Medicine evaluated more than 150 studies on polyphenols in cancer for ...
(Date:5/20/2016)... ... May 20, 2016 , ... Korean researchers say Manumycin A triggers ... a new way to treat the disease. Surviving Mesothelioma has just posted an article ... from several Korean institutions based their mesothelioma study on the fact the Manumycin A, ...
(Date:5/19/2016)... , May 19, 2016  AdvancedFlow Systems ... Inc. (AGI), based out of Maple ... Biogas Ltd. to its existing portfolio of contract ... agreement. AFS along with its sister companies Surround ... a vertically integrated industrial group that specializes in ...
(Date:5/19/2016)... May 19, 2016 ... (OTC PINK: RGBPP) announced today initiation of a ... cord blood based cancer immunotherapeutic product leveraging its ... Regen described a generation of cord blood derived ... gene silencing.  The product in development will be ...
Breaking Biology Technology:
Cached News: